BMS CELMoD Limited Dispensing Network: Prospective Pharmacy Information Form
Thank you for your interest in dispensing iberdomide and mezigdomide*. Iberdomide and mezigdomide are subject to a REMS
program and have a limited dispensing network. The limited dispensing network is currently
at capacity and closed. If your site would like to be considered for inclusion if the
network were updated in the future, please complete the form below. Providing this information does not guarantee inclusion in the network. Please complete the form for
each dispensing site that you would like to be considered.
*Investigational asset that is not yet FDA approved